lungfusion-panel

LungFUSION Panel

Screen for ALK, RET & ROS1 translocations in Non-Small Cell Lung Carcinoma (NSCLC)

LungFUSION Panel v1.0 offers a rapid screening method for detecting an oncogenic fusion partner in ALK, RET or ROS1 genes.

lungfusion-panel
What it screen?
What it screen?

GENES Covered

LEARN MORE

  • ALK
  • RET
  • ROS1
Benefits
Benefits

LEARN MORE

Can utilise a minimal 10ng cDNA template in a single well assay.

Fusion partners in any of these genes have been correlated with targeted therapies for the treatment of lung cancer

Built-in EML4 controls to determine endogenous expression of wild-type lung tissue.

MyFitBabyPlus

Stepping into Motherhood ?
MyBabyFitPlus
Benefits

FREE Sample Collection

PAN India Logistics

Accurate Reporting

Fast TAT

Stringent QC

ibrandox